Product explained
What Renoxome & Renoxome+ is
Renoxome is described by Koru as a biocompatible exosome formula with sodium hyaluronate; Renoxome+ uses plant-derived extracellular-vesicle material with PDRN. At Idalia these products are offered topically alongside controlled microneedling and are not advertised or administered as injectable exosome treatments.
Who may consider it
- Texture, hydration and recovery-focused microneedling plans after a skin review.
- People who want a Korean professional topical paired with controlled needling.
- A comparison with standard microneedling, PRP/PRF or injectable skin boosters before choosing.
How treatment is planned
Goals, anatomy, skin or scalp condition, medical history, medication and previous treatment are reviewed.
The exact formula, intended route, batch, expiry, current instructions and practitioner scope are checked.
Area, amount, technique, comfort measures and photographs are agreed before consent.
Response, recovery and whether another session is appropriate are assessed without automatic treatment.
Risks, recovery and limits
- Redness, swelling, tenderness, bruising and temporary unevenness can occur.
- Injectable and thread treatments carry uncommon but potentially serious risks discussed in person before consent.
- Active infection, pregnancy or breastfeeding, medication and some medical conditions can change suitability.
- Results and duration vary. No fixed outcome, lift, regrowth, volume or number of sessions is guaranteed.
Manufacturer information
This guide supports—not replaces—a clinical consultation. Read the Koru Pharma: Renoxome. Current UK supply status, instructions and practitioner requirements are checked before any product is offered.